Rockwell Medical (NASDAQ: RMTI)
Q2 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2022-08-15 | ||||||
REV |
Q1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.840 | ||||||
REV | 17.650M | 16.124M | -1.526M |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Rockwell Medical (NASDAQ: RMTI) through any online brokerage.
Other companies in Rockwell Medical’s space includes: TELA Bio (NASDAQ:TELA), Chembio Diagnostics (NASDAQ:CEMI), Predictive Oncology (NASDAQ:POAI), Meihua International (NASDAQ:MHUA) and InspireMD (NASDAQ:NSPR).
The latest price target for Rockwell Medical (NASDAQ: RMTI) was reported by HC Wainwright & Co. on Tuesday, January 18, 2022. The analyst firm set a price target for 3.00 expecting RMTI to rise to within 12 months (a possible 120.59% upside). 2 analyst firms have reported ratings in the last year.
The stock price for Rockwell Medical (NASDAQ: RMTI) is $1.36 last updated June 28, 2022, 8:00 PM UTC.
There are no upcoming dividends for Rockwell Medical.
Rockwell Medical’s Q2 earnings are confirmed for Monday, August 15, 2022.
There is no upcoming split for Rockwell Medical.
Rockwell Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.